Antivirale Nukleosid-Derivate

European patent · EP0393920 · Deleted

Register entry

Publication number
EP0393920
Application number
EP90303904
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Apr 11, 1990
Published
Oct 24, 1990
Granted
Jul 9, 1997
Deleted
Apr 10, 2010
Reason
Maximum term reached
IPC classes
C07H 19/06 (2006.01)
C07D 473/00 (2006.01)
A61K 31/70 (2006.01)
A61K 31/52 (2006.01)
Priority
GB 8908646 17.04.1989
GB 8921266 20.09.1989
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 12, 2010

    Maximum term reached

    Published in Swissreg on 12.04.2010

  2. Oct 31, 2005

    Transferred

    Owner
    Scotia Holdings plc, Efamol House, Woodbridge Meadows, Guildford (Surrey GU1 1BA), United Kingdom → PROTARGA, INC., 2200 Renaissance Blvd., Suite 450, King of Prussia, PA 19406, USA

    Published in +pat+ No 20 in 2005

  3. Oct 31, 2005

    Transferred

    Owner
    PROTARGA, INC., 2200 Renaissance Blvd., Suite 450, King of Prussia, PA 19406, USA → Luitpold Pharmaceuticals, Inc., One Luitpold Drive, Shirley, NY 11967, USA

    Published in +pat+ No 20 in 2005

  4. Jul 15, 1997

    Agent entered

    Representative
    R. A. Egli & Co., Patentanwälte, Horneggstrasse 4, 8008 Zürich

    Published in PIDTJ No 13 in 1997

  5. Jul 15, 1997

    Granted

    Published in PIDTJ No 13 in 1997

Parties

Inventor

Horrobin, David Frederick, Scotia

Guildford, Surrey GU1 1BA, GB

Stewart, John Charles Marshall, Scotia

Guildford, Surrey GU1 1BA, GB

Winther, Michael David, Scotia

Guildford, Surrey GU1 1BA, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.